The first data on the effects of anti-TNFα therapy were drawn from patients with arthritis who seemed to have no increased risk to develop new or recurrent cancer after exposure to anti-TNFα compared to patients without anti-TNFα therapy [16]. This evidence concerns the gene TNF and arthritic joint disease.